Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Weiss

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Thrombosis and Haemostasis|February 24, 2017
Platelet turnover predicts outcome after coronary interventionMatthias K Freynhofer, Liana Iliev, Veronika Bruno, et al.
The FEBS Journal|April 11, 2007
Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factorPhilip B Daniel, Wolfram Lux, Andre L Samson, et al.
Mediators of Inflammation|June 10, 2017
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery DiseaseIda Unhammer Njerve, Sissel Åkra, Thomas W Weiss, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2016
Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarctionBarbara Fellner, Miklos Rohla, Rudolf Jarai, et al.
Cytokine|April 15, 2014
An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosisSvitlana Demyanets, Ioannis Tentzeris, Rudolf Jarai, et al.
The American Journal of Managed Care|June 8, 2006
Interactive voice response telephone calls to enhance bone mineral density testingJennifer M Polinski, Amanda Patrick, Colleen Truppo, et al.
The American Journal of Managed Care|November 20, 2002
Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practicesMary N Walsh, Ross J Simpson, George J Wan, et al.
Thrombosis Research|July 13, 2023
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Serdar Farhan, Matthias K Freynhofer, et al.
Preventing Chronic Disease|June 21, 2005
Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settingsPatrick J O'Connor, Richard J Gray, Michael V Maciosek, et al.
Thrombosis Research|August 24, 2020
Von Willebrand Factor and ADAMTS13 and long-term outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Ioannis Tentzeris, Birgit Vogel, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Thrombosis and Haemostasis|February 24, 2017
Platelet turnover predicts outcome after coronary interventionMatthias K Freynhofer, Liana Iliev, Veronika Bruno, et al.
The FEBS Journal|April 11, 2007
Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factorPhilip B Daniel, Wolfram Lux, Andre L Samson, et al.
Mediators of Inflammation|June 10, 2017
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery DiseaseIda Unhammer Njerve, Sissel Åkra, Thomas W Weiss, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2016
Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarctionBarbara Fellner, Miklos Rohla, Rudolf Jarai, et al.
Cytokine|April 15, 2014
An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosisSvitlana Demyanets, Ioannis Tentzeris, Rudolf Jarai, et al.
The American Journal of Managed Care|June 8, 2006
Interactive voice response telephone calls to enhance bone mineral density testingJennifer M Polinski, Amanda Patrick, Colleen Truppo, et al.
The American Journal of Managed Care|November 20, 2002
Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practicesMary N Walsh, Ross J Simpson, George J Wan, et al.
Thrombosis Research|July 13, 2023
Blood group non-O is not associated with long-term adverse outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Serdar Farhan, Matthias K Freynhofer, et al.
Preventing Chronic Disease|June 21, 2005
Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settingsPatrick J O'Connor, Richard J Gray, Michael V Maciosek, et al.
Thrombosis Research|August 24, 2020
Von Willebrand Factor and ADAMTS13 and long-term outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Ioannis Tentzeris, Birgit Vogel, et al.
Pageof 10